Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes - PubMed (original) (raw)
Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes
M Gobbi et al. Eur J Pharmacol. 1993.
Abstract
The monoamine releasing activity of d-fenfluramine was investigated with an in vitro model consisting of synaptosomes preloaded with the 3H-neurotransmitter and extensively washed in a superfusion apparatus before a 3-min exposure to d-fenfluramine. With this model, the drug-induced release is real and is not confused by inhibition of reuptake by the drug. d-Fenfluramine (0.5 microM) induced only [3H]5-hydroxytryptamine ([3H]5-HT) release from hippocampal synaptosomes whereas 10 microM also induced some overflow from hippocampal synaptosomes preloaded with [3H]noradrenaline or from striatal synaptosomes preloaded with [3H]dopamine, although the overflow was much lower than from 5-HTergic synaptosomes. We then focused on the [3H]5-HT release induced by 0.5 microM d-fenfluramine, which was previously shown to be Ca2+ dependent. The same finding was confirmed in the present study with other experimental protocols, indicating the requirement for extracellular Ca2+ ions. By measuring [3H]5-HT uptake into rat hippocampal synaptosomes we confirmed that Ca(2+)-ions are not required for the function of the 5-HT uptake carrier or for its interaction with d-fenfluramine. d-Fenfluramine-induced [3H]5-HT release was not altered by 1 microM nitrendipine (blocking the L-type Ca2+ channels) but was slightly decreased (20%) by 0.5 microM omega-conotoxin (blocking the N-type Ca2+ channels). It was also inhibited by 0.5 microM clonidine, interacting with alpha 2-adrenergic heteroreceptors, and by 10 nM tetanus toxin, known to affect the exocytosis of different neurotransmitters including 5-HT. These compounds had very similar effects on the Ca(2+)-dependent, exocytotic release of [3H]5-HT induced by depolarization, i.e. by 15 mM K+.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Involvement of P-type Ca2+ channels in the K(+)- and d-fenfluramine-induced [3H]5-HT release from rat hippocampal synaptosomes.
Frittoli E, Gobbi M, Mennini T. Frittoli E, et al. Neuropharmacology. 1994 Jun;33(6):833-5. doi: 10.1016/0028-3908(94)90123-6. Neuropharmacology. 1994. PMID: 7936121 - Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin.
Gobbi M, Frittoli E, Mennini T, Garattini S. Gobbi M, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jan;345(1):1-6. doi: 10.1007/BF00175461. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1538789 - Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D, Mennini T, Gobbi M. Crespi D, et al. Br J Pharmacol. 1997 Aug;121(8):1735-43. doi: 10.1038/sj.bjp.0701325. Br J Pharmacol. 1997. PMID: 9283711 Free PMC article. - Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
Malva JO, Carvalho AP, Carvalho CM. Malva JO, et al. Br J Pharmacol. 1994 Dec;113(4):1439-47. doi: 10.1111/j.1476-5381.1994.tb17158.x. Br J Pharmacol. 1994. PMID: 7534187 Free PMC article. - Therapeutic and adverse actions of serotonin transporter substrates.
Rothman RB, Baumann MH. Rothman RB, et al. Pharmacol Ther. 2002 Jul;95(1):73-88. doi: 10.1016/s0163-7258(02)00234-6. Pharmacol Ther. 2002. PMID: 12163129 Review.
Cited by
- Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences.
Quinlan MA, Krout D, Katamish RM, Robson MJ, Nettesheim C, Gresch PJ, Mash DC, Henry LK, Blakely RD. Quinlan MA, et al. ACS Chem Neurosci. 2019 Jul 17;10(7):3249-3260. doi: 10.1021/acschemneuro.8b00689. Epub 2019 Feb 5. ACS Chem Neurosci. 2019. PMID: 30668912 Free PMC article. - Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.
Zhang G, Krishnamoorthy S, Ma Z, Vukovich NP, Huang X, Tao R. Zhang G, et al. Eur J Pharmacol. 2009 Aug 1;615(1-3):66-75. doi: 10.1016/j.ejphar.2009.05.008. Epub 2009 May 20. Eur J Pharmacol. 2009. PMID: 19464285 Free PMC article. - Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice.
Nakagawasai O, Murata A, Arai Y, Ohba A, Wakui K, Mitazaki S, Niijima F, Tan-No K, Tadano T. Nakagawasai O, et al. J Neural Transm (Vienna). 2007;114(8):1003-10. doi: 10.1007/s00702-007-0655-2. Epub 2007 Mar 20. J Neural Transm (Vienna). 2007. PMID: 17372673 - Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.
Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L. Lyons WE, et al. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15239-44. doi: 10.1073/pnas.96.26.15239. Proc Natl Acad Sci U S A. 1999. PMID: 10611369 Free PMC article. - In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.
Mennini T, Fracasso C, Cagnotto A, Bergami A, Frittoli E, Gobbi M, Caccia S, Garattini S. Mennini T, et al. Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):641-7. doi: 10.1007/BF00167183. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8738297
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous